[Treatment of acute attack of migraine with sumatriptan].
BACKGROUND
In the Hospital Clínico Quirúrgico Hermanos Almeijeiras a randomized double blind clinical trial was carried out involving 52 patients who presented with painful migraine crises with or without prodromes. A group of 27 patients were given 6 mg of sumatriptan subcutaneously. Another group of 25 patients were given 1 mg of dihydroergotamine intramuscularly. It was seen that both drugs relieved the migrainous pain. However, sumatriptan did so in a greater percentage of patients.


CONCLUSIONS
There was earlier, and also more complete, relief of pain in those patients receiving sumatriptan. With regard to side-effects of sumatriptan were pain at the back of the site of injection, sensation of pressure at the back of the neck, facial flushing and asthenia.
González-Espinosa
L E
LE
Servicio de Neurología, Hospital C.Q. Hermanos Ameijeiras, Ciudad de La Habana, Cuba.
Gómez-Viera
N
N
Olivera-Leal
I
I
Reyes-Lorente
R
R
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D012720:Severity of Illness Index; D017678:Sex Distribution; D018170:Sumatriptan / Q000627:therapeutic use*; D013997:Time Factors
D017366:Serotonin Receptor Agonists; D018170:Sumatriptan
Tratamiento del ataque agudo de la cefalea migrañosa con sumatriptán.